TY  - GEN
AU  - Négrier,S
AU  - Bushmakin,A G
AU  - Cappelleri,J C
AU  - Korytowsky,B
AU  - Sandin,R
AU  - Charbonneau,C
AU  - Michaelson,M D
AU  - Figlin,R A
AU  - Motzer,R J
TI  - Assessment of progression-free survival as a surrogate end-point for overall survival in patients with metastatic renal cell carcinoma
SN  - 1879-0852
PY  - 2014///0718
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Endpoint Determination
KW  - Humans
KW  - Indoles
KW  - Interferon-alpha
KW  - Kaplan-Meier Estimate
KW  - Kidney Neoplasms
KW  - Multicenter Studies as Topic
KW  - Pyrroles
KW  - Randomized Controlled Trials as Topic
KW  - Retrospective Studies
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sunitinib
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejca.2014.03.012
ER  -